These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Organoid models for translational pancreatic cancer research. Tiriac H; Plenker D; Baker LA; Tuveson DA Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513 [TBL] [Abstract][Full Text] [Related]
5. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants. Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795 [TBL] [Abstract][Full Text] [Related]
6. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology. Bazzichetto C; Luchini C; Conciatori F; Vaccaro V; Di Cello I; Mattiolo P; Falcone I; Ferretti G; Scarpa A; Cognetti F; Milella M Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266496 [TBL] [Abstract][Full Text] [Related]
7. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options. Semaan A; Maitra A Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774 [No Abstract] [Full Text] [Related]
13. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer. Malgerud L; Lindberg J; Wirta V; Gustafsson-Liljefors M; Karimi M; Moro CF; Stecker K; Picker A; Huelsewig C; Stein M; Bohnert R; Del Chiaro M; Haas SL; Heuchel RL; Permert J; Maeurer MJ; Brock S; Verbeke CS; Engstrand L; Jackson DB; Grönberg H; Löhr JM Mol Oncol; 2017 Oct; 11(10):1413-1429. PubMed ID: 28675654 [TBL] [Abstract][Full Text] [Related]
14. Can we move towards personalised pancreatic cancer therapy? Jamieson NB; Chang DK; Grimmond SM; Biankin AV Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):335-8. PubMed ID: 24702631 [No Abstract] [Full Text] [Related]
15. Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities. Wang Y; Lakoma A; Zogopoulos G Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967105 [TBL] [Abstract][Full Text] [Related]
16. Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer. Takai E; Totoki Y; Nakamura H; Kato M; Shibata T; Yachida S Adv Exp Med Biol; 2016; 924():13-17. PubMed ID: 27753011 [TBL] [Abstract][Full Text] [Related]
17. Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma. Bai RL; Wang NY; Zhao LL; Zhang YF; Cui JW Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):10-24. PubMed ID: 34538570 [TBL] [Abstract][Full Text] [Related]
18. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience. Lowder CY; Dhir T; Goetz AB; Thomsett HL; Bender J; Tatarian T; Madhavan S; Petricoin EF; Blais E; Lavu H; Winter JM; Posey J; Brody JR; Pishvaian MJ; Yeo CJ Surg Oncol; 2020 Jun; 33():118-125. PubMed ID: 32561076 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer subtypes: a roadmap for precision medicine. Torres C; Grippo PJ Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309 [TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong? Connor AA; Gallinger S Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):683-694. PubMed ID: 28460572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]